glp-1 news today cardiovascular outcomes 2025 november Studies Add to Growing Body of Evidence Demonstrating Significant Benefit on GLP-1 Pipeline Update: November 2025

Always follow your healthcare provider's advice regarding the appropriateness of GLP-1 analogue treatments for your age group

Plasma insulin stimulates tyrosine phosphorylation of STAT3 in the liver, and hepatic IL-6 that is induced by the brain-insulin action is necessary for the activation of STAT3 (Inoue et al., 2006)

Then, over 30 years ago, clinicians began to see the value of incretin-based therapy for T2DM, which led to a plethora of clinical trials confirming that GLP-1 receptor agonists are effective in the management of T2DM

This discovery formed the scientific basis for the development of AOD-9604 as a focused research tool for metabolic biology investigation

GLP therapies are transforming metabolic care, but their full impact depends on how well we can monitor and understand patient outcomes beyond the prescription, said Neeraj Katare , Founder, Tracky

Changes in pigment profiles of Haematococcus pluvialis during exposure to environmental stresses